These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3861174)

  • 1. Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion.
    Bett JH; Wilkinson RK; Boyle CM
    Aust N Z J Med; 1985 Apr; 15(2):270. PubMed ID: 3861174
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion.
    Rowbotham B; Roeser HP
    Aust N Z J Med; 1984 Oct; 14(5):667-9. PubMed ID: 6597712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin in the treatment of iron overload in a patient with hemolytic anemia and pyruvate kinase deficiency.
    Vukelja SJ
    Acta Haematol; 1994; 91(4):199-200. PubMed ID: 7976118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.
    van Beers EJ; van Straaten S; Morton DH; Barcellini W; Eber SW; Glader B; Yaish HM; Chonat S; Kwiatkowski JL; Rothman JA; Sharma M; Neufeld EJ; Sheth S; Despotovic JM; Kollmar N; Pospíšilová D; Knoll CM; Kuo K; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Verhovsek M; Kunz J; McNaull MA; Rose MJ; Bradeen HA; Addonizio K; Li A; Al-Sayegh H; London WB; Grace RF
    Haematologica; 2019 Feb; 104(2):e51-e53. PubMed ID: 30213831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iron overload in congenital hemolytic anemia caused by pyruvate kinase deficiency. A major late complication].
    Boivin P; Galand C
    Presse Med; 1990 Jun; 19(23):1087-90. PubMed ID: 2141411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congestive cardiomyopathy and haemochromatosis--rapid progression possibly accelerated by excessive ingestion of ascorbic acid.
    McLaran CJ; Bett JH; Nye JA; Halliday JW
    Aust N Z J Med; 1982 Apr; 12(2):187-8. PubMed ID: 6953962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpectedly high but still asymptomatic iron overload in a patient with pyruvate kinase deficiency.
    Andersen FD; d'Amore F; Nielsen FC; van Solinge W; Jensen F; Jensen PD
    Hematol J; 2004; 5(6):543-5. PubMed ID: 15570302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin C and iron overload.
    Herbert V
    N Engl J Med; 1981 Apr; 304(18):1108. PubMed ID: 7207576
    [No Abstract]   [Full Text] [Related]  

  • 9. Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios.
    Mojzikova R; Koralkova P; Holub D; Zidova Z; Pospisilova D; Cermak J; Striezencova Laluhova Z; Indrak K; Sukova M; Partschova M; Kucerova J; Horvathova M; Divoky V
    Br J Haematol; 2014 May; 165(4):556-63. PubMed ID: 24533562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase deficiency in pregnancy complicated by iron overload.
    Dolan LM; Ryan M; Moohan J
    BJOG; 2002 Jul; 109(7):844-6. PubMed ID: 12135225
    [No Abstract]   [Full Text] [Related]  

  • 11. The dangers of iron overload in pyruvate kinase deficiency.
    Marshall SR; Saunders PW; Hamilton PJ; Taylor PR
    Br J Haematol; 2003 Mar; 120(6):1090-1. PubMed ID: 12648084
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
    Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
    Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare combination of two inherited disorders in one patient: pyruvate kinase deficiency and hemochromatosis.
    Arnold H; Blume KG
    Ann Hematol; 2009 Aug; 88(8):815-6. PubMed ID: 19137298
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron status in red cell pyruvate kinase deficiency: study of Italian cases.
    Zanella A; Berzuini A; Colombo MB; Guffanti A; Lecchi L; Poli F; Cappellini MD; Barosi G
    Br J Haematol; 1993 Mar; 83(3):485-90. PubMed ID: 8485056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse Char10 locus regulates severity of pyruvate kinase deficiency and susceptibility to malaria.
    Laroque A; Min-Oo G; Tam M; Ponka P; Stevenson MM; Gros P
    PLoS One; 2017; 12(5):e0177818. PubMed ID: 28542307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferasirox in pyruvate kinase deficiency.
    Deeren D
    Ann Hematol; 2009 Apr; 88(4):397. PubMed ID: 18810437
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.
    Hilgard P; Gerken G
    World J Gastroenterol; 2005 Feb; 11(8):1241-4. PubMed ID: 15754414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascorbic acid safety: analysis of factors affecting iron absorption.
    Bendich A; Cohen M
    Toxicol Lett; 1990 Apr; 51(2):189-201. PubMed ID: 2184546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemochromatosis and puryvate kinase deficiency (author's transl)].
    Noël D; Duron F; Thomas M
    Ann Med Interne (Paris); 1979 Dec; 130(12):679-83. PubMed ID: 539687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autopsy case of pyruvate kinase deficiency anemia associated with severe hemochromatosis.
    Nagai H; Takazakura E; Oda H; Tsuji H; Terada Y; Makino H; Yamauchi H; Saitoh K
    Intern Med; 1994 Jan; 33(1):56-9. PubMed ID: 8180445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.